DBV Technologies | Der Umsatz





Der Umsatz Veränderung Datum
Acadia Pharmaceuticals USD 278.6M 14M 2025-09
Alnylam Pharmaceuticals USD 1.25B 476.31M 2025-09
Amarin USD 49.67M 23.07M 2025-09
BioCryst Pharmaceuticals USD -86.95M 204.03M 2024-12
BioMarin Pharmaceutical USD 776M 49M 2025-09
DBV Technologies USD 2.77M 1.31M 2025-09
Esperion Therapeutics USD 51.63M 22.2M 2024-09
Halozyme Therapeutics USD 354M 148M 2025-09
Incyte USD 1.51B 140M 2025-12
Insmed USD 142M 34.6M 2025-09
Ionis Pharmaceuticals USD 157M 295M 2025-09
Neurocrine Biosciences USD 805.5M 10.6M 2025-12
PTC Therapeutics USD 211M 32.1M 2025-09
Sarepta Therapeutics USD 399.4M 211.69M 2025-09
Ultragenyx Pharmaceutical USD 160M 6.5M 2025-09
United Therapeutics USD 799.5M 900K 2025-09


DBV Technologies Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.